Dayno Jeffrey M. 4
4 · Harmony Biosciences Holdings, Inc. · Filed Jan 26, 2026
Research Summary
AI-generated summary of this filing
Harmony Biosciences (HRMY) CEO Jeffrey Dayno Receives RSUs, Exercises Options
What Happened
Jeffrey M. Dayno, President, CEO and a director of Harmony Biosciences (HRMY), received derivative awards (restricted stock units / option-related awards) totaling 237,500 units on Jan 22, 2026 (184,600 + 52,900). He also exercised/converted a total of 23,500 option shares on Jan 24–25, 2026 (10,500 and 13,000). To satisfy required tax withholdings, the issuer withheld 4,785 shares (Jan 24) and 5,654 shares (Jan 25) at $36.82 per share, generating cash withholding amounts of $176,184 and $208,180 (combined $384,364). The grants are derivative awards (RSUs/options) with vesting schedules noted in the filing.
Key Details
- Transaction dates/prices:
- Jan 22, 2026: Grant/award of 184,600 and 52,900 derivative units (reported as acquired at $0.00; RSU/derivative).
- Jan 24, 2026: Exercise/conversion of 10,500 shares (acquired), and 4,785 shares withheld for tax at $36.82 ($176,184).
- Jan 25, 2026: Exercise/conversion of 13,000 shares (acquired), and 5,654 shares withheld for tax at $36.82 ($208,180).
- Shares withheld for taxes: 10,439 total shares; withholding cash value $384,364.
- Shares owned after the transactions: not specified in the provided Form 4 summary.
- Footnotes of note:
- F1: Shares were withheld by the issuer to satisfy income tax withholding on RSU vesting.
- F2–F5: Awards/options are subject to multi-year vesting schedules (vesting begins on various dates in 2025–2027 and may vest quarterly or annually as specified).
- Filing timeliness: no late filing flag is indicated in the information provided.
Context and plain-language takeaways:
- These filings show a mix of awards (acquisitions of RSU/derivative interests) and option exercises. The large entry on Jan 22 is an award/grant (acquisition) but the awards vest over future dates—so they are not immediately liquid shares.
- The exercised option shares had portions withheld to cover tax obligations (a common, non-market sale administrative action), not open-market stock sales. That withholding is recorded as a disposal (F) for tax purposes.
- For retail investors: awards/RSUs indicate compensation and potential future share issuance subject to vesting; the withheld shares for taxes are routine and do not necessarily indicate a decision to sell stock for investment reasons.
Insider Transaction Report
Form 4
Dayno Jeffrey M.
DirectorPRESIDENT, CEO
Transactions
- Exercise/Conversion
Common Stock
2026-01-24+10,500→ 10,500 total - Tax Payment
Common Stock
[F1]2026-01-24$36.82/sh−4,785$176,184→ 5,715 total - Exercise/Conversion
Common Stock
2026-01-25+13,000→ 13,000 total - Tax Payment
Common Stock
[F1]2026-01-25$36.82/sh−5,654$208,180→ 7,346 total - Award
Stock Option
[F2]2026-01-22+184,600→ 184,600 totalExercise: $36.76Exp: 2036-01-22→ Common Stock (184,600 underlying) - Award
Restricted Stock Units
[F3]2026-01-22+52,900→ 52,900 total→ Common Stock (52,900 underlying) - Exercise/Conversion
Restricted Stock Units
[F4]2026-01-24−10,500→ 21,000 total→ Common Stock (10,500 underlying) - Exercise/Conversion
Restricted Stock Units
[F5]2026-01-25−13,000→ 39,000 total→ Common Stock (13,000 underlying)
Footnotes (5)
- [F1]Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
- [F2]The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F3]The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- [F4]This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- [F5]This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Signature
/s/ Christian Ulrich, Attorney-in-Fact|2026-01-26